Down syndrome: Is it really characterized by precocious immunosenescence?

Aging and Disease

Volumn 2, Issue 6, 2011, Pages 538-545

  Kusters, Maaike A A ^a,b   Verstegen, Ruud H J ^a,c   de Vries, Esther ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Adaptive immune system; Down syndrome; Immunosenescence; Progeria syndromes

Indexed keywords

EID: 84871826330     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: None     Document Type: Review

References (44)

1. Andrews NP, Fujii H, Goronzy JJ and Weyand CM (2010). Telomeres and immunological diseases of aging. Gerontology, 56: 390-403
2. Shay JW and Wright WE (2005). Senescence and immortalization: role of telomeres and telomerase. Carcinogenesis, 26: 867-874
3. Ponnappan S and Ponnappan U (2011). Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal, 14: 1551-1585
4. Weiskopf D, Weinberger B and Grubeck-Loebenstein B (2009). The aging of the immune system. Transpl Int, 22: 1041-1050
5. Lott IT (1982). Down's syndrome, aging, and Alzheimer's disease: a clinical review. Ann N Y Acad Sci, 396: 15-27
6. Cuadrado E and Barrena MJ (1996). Immune dysfunction in Down's syndrome: primary immune deficiency or early senescence of the immune system? Clin Immunol Immunopathol, 78: 209-214
7. Burtner CR and Kennedy BK (2010). Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol, 11: 567-578
8. Kusters MA, Verstegen RH, Gemen EF and de Vries E (2009). Intrinsic defect of the immune system in children with Down syndrome: a review. Clin Exp Immunol, 156: 189-193
9. Roitt IM, Brostoff J, Male D, editors. Immunology fifth edition. St Louis: CV Mosby, 1985
10. Roat E, Prada N, Lugli E, Nasi M, Ferraresi R, Troiano L, Giovenzana C, Pinti M, Biagioni O, Mariotti M, Di Iorio A, Consolo U, Balli F and Cossarizza A (2008). Homeostatic cytokines and expansion of regulatory T cells accompany thymic impairment in children with Down syndrome. Rejuvenation Res, 11: 573-583
11. Murphy M, Insoft RM, Pike-Nobile L, Derbin KS and Epstein LB (1993). Overexpression of LFA-1 and ICAM-1 in Down syndrome thymus. Implications for abnormal thymocyte maturation. J Immunol, 150: 5696-5703
12. Kusters MA, Gemen EF, Verstegen RH, Wever PC and E DEV (2010). Both normal memory counts and decreased naive cells favor intrinsic defect over early senescence of Down syndrome T lymphocytes. Pediatr Res, 67: 557-562
13. Trotta MB, Serro Azul JB, Wajngarten M, Fonseca SG, Goldberg AC, Kalil JE (2011). Inflammatory and immunological parameters in adults with Down syndrome. Immun Ageing, 8:4.
14. de Arruda Cardoso Smith M, Borsatto-Galera B, Feller RI, Goncalves A, Oyama RS, Segato R (2004). Telomeres on chromosome 21 and aging in lymphocytes and gingival fibroblasts from individuals with Down syndrome. J Oral Sci, 46:171-7.
15. Jenkins EC, Velinov MT, Ye L, Gu H, Li S, Jenkins EC, Jr., Brooks SS, Pang D, Devenny DA, Zigman WB, Schupf N and Silverman WP (2006). Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging, 27: 941-945
16. Vaziri H, Schachter F, Uchida I, Wei L, Zhu X, Effros R, Cohen D and Harley CB (1993). Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet, 52: 661-667
17. Abu Faddan N, Sayed D and Ghaleb F (2011). T lymphocytes apoptosis and mitochondrial membrane potential in Down's syndrome. Fetal Pediatr Pathol, 30: 45-52
18. Roat E, Prada N, Ferraresi R, Giovenzana C, Nasi M, Troiano L, Pinti M, Nemes E, Lugli E, Biagioni O, Mariotti M, Ciacci L, Consolo U, Balli F and Cossarizza A (2007). Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett, 581: 521-525
19. de Hingh YC, van der Vossen PW, Gemen EF, Mulder AB, Hop WC, Brus F and de Vries E (2005). Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr, 147: 744-747
20. Cetiner S, Demirhan O, Inal TC, Tastemir D, Sertdemir Y (2010). Analysis of peripheral blood T-cell subsets, natural killer cells and serum levels of cytokines in children with Down syndrome. Int J Immunogenet, 37:233-237.
21. Verstegen RH, Kusters MA, Gemen EF and E DEV (2010). Down syndrome B-lymphocyte subpopulations, intrinsic defect or decreased T-lymphocyte help. Pediatr Res, 67: 563-569
22. Gross PA, Hermogenes AW, Sacks HS, Lau J and Levandowski RA (1995). The efficacy of influenza vaccine in elderly persons. A meta-analysis and review of the literature. Ann Intern Med, 123: 518-527
23. Hainz U, Jenewein B, Asch E, Pfeiffer KP, Berger P and Grubeck-Loebenstein B (2005). Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine, 23: 3232-3235
24. Lee H, Nahm MH and Kim KH (2010). The effect of age on the response to the pneumococcal polysaccharide vaccine. BMC Infect Dis, 10: 60
25. Kusters MA, Jol-van der Zijde CM, van Tol MJ, Bolz WE, Bok LA, Visser M and de Vries E (2011). Impaired avidity maturation after tetanus toxoid booster in children with Down syndrome. Pediatr Infect Dis J, 30: 357-359
26. Philip R, Berger AC, McManus NH, Warner NH, Peacock MA and Epstein LB (1986). Abnormalities of the in vitro cellular and humoral responses to tetanus and influenza antigens with concomitant numerical alterations in lymphocyte subsets in Down syndrome (trisomy 21). J Immunol, 136: 1661-1667
27. Costa-Carvalho BT, Martinez RM, Dias AT, Kubo CA, Barros-Nunes P, Leiva L, Sole D, Carneiro-Sampaio MM, Naspitz CK and Sorensen RU (2006). Antibody response to pneumococcal capsular polysaccharide vaccine in Down syndrome patients. Braz J Med Biol Res, 39: 1587-1592
28. Joshi AY, Abraham RS, Snyder MR, Boyce TG (2011) Immune evaluation and vaccine responses in Down syndrome: evidence of immunodeficiency? Vaccine, 29:5040-6
29. Goronzy JJ and Weyand CM (2003). Aging, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity - catalysts of autoimmunity and chronic inflammation. Arthritis Res Ther, 5: 225-234
30. Bloemers BLP, Broers CJM, Bont L, Weijerman ME, Gemke RJBJ, van Furth AM (2010). Increased risk of respiratory tract infections in children with Down syndrome: the consequence of an altered immune system. Microbes Infect, 12:799-808.
31. Lang D. Susceptibility to infectious disease in Down syndrome. In: Lott IT, McCoy EE, editors. Down syndrome: advances in medical care. New York: Wiley-Liss; 1992. p. 83-92.
32. Day SM, Strauss DJ, Shavelle RM and Reynolds RJ (2005). Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol, 47: 171-176
33. Karlsson B, Gustafsson J, Hedov G, Ivarsson SA and Anneren G (1998). Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child, 79: 242-245
34. Sanchez-Albisua I, Storm W, Wascher I and Stern M (2002). How frequent is coeliac disease in Down syndrome? Eur J Pediatr, 161: 683-684
35. Anwar AJ, Walker JD and Frier BM (1998). Type 1 diabetes mellitus and Down's syndrome: prevalence, management and diabetic complications. Diabet Med, 15: 160-163
36. Goldacre MJ, Wotton CJ, Seagroatt V and Yeates D (2004). Cancers and immune related diseases associated with Down's syndrome: a record linkage study. Arch Dis Child, 89: 1014-1017
37. Ozgenc A and Loeb LA (2006). Werner Syndrome, aging and cancer. Genome Dyn, 1: 206-217
38. Harjacek M, Batinic D, Sarnavka V, Uzarevic B, Mardesic D, Marusic M. Immunological aspects of progeria (Hutchinson-Gilford syndrome) in a 15-month-old child. Eur J Pediatr. 1990;150:40-2.
39. Merideth MA, Gordon LB, Clauss S, Sachdev V, Smith AC, Perry MB, Brewer CC, Zalewski C, Kim HJ, Solomon B, Brooks BP, Gerber LH, Turner ML, Domingo DL, Hart TC, Graf J, Reynolds JC, Gropman A, Yanovski JA, Gerhard-Herman M, Collins FS, Nabel EG, Cannon RO 3rd, Gahl WA, Introne WJ (2008). Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med, 358:592-606.
40. Nakao Y, Hattori T, Takatsuki K, Kuroda Y, Nakaji T, Fujiwara Y, Kishihara M, Baba Y, Fujita T (1980). Immunologic studies on Werner's syndrome. Clin Exp Immunol, 42:10-9.
41. Ozgenc A, Loeb LA (2006). Werner Syndrome, aging and cancer. Genome Dyn, 1:206-17.
42. Norris PG, Limb GA, Hamblin AS, Lehmann AR, Arlett CF, Cole J, Waugh AP, Hawk JL (1990). Immune function, mutant frequency, and cancer risk in the DNA repair defective genodermatoses xeroderma pigmentosum, Cockayne's syndrome, and trichothiodystrophy. J Invest Dermatol, 94:94-100.
43. Wysenbeek AJ, Weiss H, Duczyminer-Kahana M, Grunwald MH, Pick AI (1986). Immunologic alterations in xeroderma pigmentosum patients. Cancer, 58:219-221.
44. Berkel AI, Kiran O (1974). Immunological studies in children with xeroderma pigmentosum. Turk J Paed, 16:43-52.